Related Experiment Video
Updated: Jul 7, 2026
07:30
Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
Published on: October 13, 2017
Managing Nasal Ischemia and Necrosis Post-Triamcinolone Injection: A New Case Series
Shahriar Nazari1,2, Nima Hadadian2, Foroohe Bayatparidary2,3
1Department of ENT and Head and Neck Surgery, BMI Hospital, Tehran, Iran.
Case Reports in Otolaryngology
|July 6, 2026
Summary
Triamcinolone injections, commonly used after rhinoplasty, can cause nasal ischemia and necrosis. This case series details management strategies, including the THIS and FAT protocol, to improve tissue recovery and outcomes.
Area of Science:
- Plastic Surgery
- Dermatology
- Ophthalmology
Background:
- Nasal ischemia and necrosis are potential complications of cosmetic injections.
- Triamcinolone injections are frequently used post-rhinoplasty to manage inflammation and deformity.
- While retinal artery occlusion is a known risk, nasal complications are less documented.
Purpose of the Study:
- To report the first cases of nasal necrosis following triamcinolone injection.
- To explore effective management strategies for post-injection nasal ischemia.
- To present a comprehensive treatment protocol for this complication.
Main Methods:
- Case series documenting four patients with nasal ischemia post-triamcinolone injection.
- Detailed description of vascular involvement, including columellar, dorsal, and lateral nasal arteries.
- Application of the THIS and FAT protocol (toxins, hyaluronidase, platelet-rich fibrin), antibiotics, and hyperbaric oxygen therapy (HBOT).
Main Results:
- Nasal necrosis occurred in patients receiving triamcinolone injections post-cosmetic surgery.
- The described treatment protocol showed potential for enhancing tissue recovery.
- Individualized treatment plans are crucial for managing nasal ischemia effectively.
Conclusions:
- Triamcinolone injections carry a risk of nasal ischemia and necrosis.
- The THIS and FAT protocol, alongside HBOT and antibiotics, offers a promising therapeutic approach.
- Customized management is essential for optimizing outcomes in patients experiencing nasal complications.
